Skip to main content
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
9.37
+0.06 (0.64%)
At close: Nov 13, 2026, 4:00 PM EST
9.50
+0.13 (1.39%)
After-hours: Nov 13, 2026, 7:30 PM EST

Monte Rosa Therapeutics Revenue

Monte Rosa Therapeutics had revenue of $54.37M in the quarter ending September 30, 2026, with 325.80% growth. This brings the company's total for the last twelve months to $70.33M, down -61.26% year-over-year. In the year 2025, Monte Rosa Therapeutics had annual revenue of $123.67M with 63.54% growth. That makes Monte Rosa Therapeutics the 25,425th largest company in the world by revenue and 3,534th in the United States.

Revenue (ttm)
$70.33M
Revenue Growth
-61.26%
P/S Ratio
11.39
Revenue / Employee
$380,135
Employees
185
Market Cap
800.67M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025123.67M48.05M63.54%
Dec 31, 202475.62M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Ardelyx468.22M
MeiraGTx Holdings401.91M
Syndax Pharmaceuticals289.68M
Lexicon Pharmaceuticals38.54M
Alumis7.40M
Revenue Rankings

GLUE News

More News